CIK 0001490978 · Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954284541
- Phone
- 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Davie Paul Jonathan See Remarks | Grant or award | +18,400 | 18,400 | ||
| 2026-11-11 | Davie Paul Jonathan See Remarks | Grant or award · Stock Option (right to buy) | +110,600 | 110,600 | ||
| 2026-11-11 | Abel Robert Lorne See Remarks | Option exercise 10b5-1 | +21,927 | $17.00 | $373K | 77,824 |
| 2026-11-11 | Abel Robert Lorne See Remarks | Sale 10b5-1 | −21,927 | $34.00 | $746K | 55,897 |
| 2026-11-11 | Abel Robert Lorne See Remarks | Sale 10b5-1 | −1,678 | $34.00 | $57K | 54,219 |
| 2026-11-11 | Abel Robert Lorne See Remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −21,927 | 72,829 | ||
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Option exercise 10b5-1 | +32,000 | $17.00 | $544K | 84,683 |
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −400 | $29.97 | $12K | 84,283 |
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −2,100 | $31.45 | $66K | 82,183 |
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −7,901 | $32.64 | $258K | 74,282 |
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −21,599 | $33.11 | $715K | 52,683 |
| 2026-11-09 | Tran Yvonne EVP, CLO & CPO | Option exercise · Stock Option (right to buy) 10b5-1 | −32,000 | 156,619 | ||
| 2026-09-17 | Akinsanya Karen See Remarks | Option exercise 10b5-1 | +31,599 | $4.34 | $137K | 101,555 |
| 2026-09-17 | Akinsanya Karen See Remarks | Sale 10b5-1 | −10,000 | $28.00 | $280K | 91,555 |
| 2026-09-17 | Akinsanya Karen See Remarks | Sale 10b5-1 | −21,599 | $30.00 | $648K | 69,956 |
| 2026-09-17 | Akinsanya Karen See Remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −31,599 | 11,599 | ||
| 2026-07-16 | Jain Rachit EVP & CFO | Sale 10b5-1 | −875 | $15.60 | $14K | 50,877 |
| 2026-06-26 | Friesner Richard Director | Gift | −679,373 | 0 | ||
| 2026-06-26 | Friesner Richard Director | Gift | +679,373 | 679,373 | ||
| 2026-06-22 | Friesner Richard Director | Grant or award | +8,141 | 690,365 |
Page 1 of 11 · 214 trades